POINT Biopharma Global Inc. - Common Stock (NQ:PNT)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Dec 26, 2023 Add to My Watchlist

Price and Volume

Volume	0
Open	-
Bid (Size)	12.49 (70)
Ask (Size)	12.51 (49)
Prev. Close	12.50
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	90,121,794
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Recent M&A Bodes Well For Targeted Cancer Therapy Player Fusion Pharmaceuticals, Analyst Say AstraZeneca Is Favorably Positioned ↗

December 27, 2023

With recent merger and acquisition deals in the targeted radiopharmaceutical therapy (TRT) space, on Tuesday, Oppenheimer noted that Fusion Pharmaceuticals Inc (NASDAQ: FUSN) is potentially the sole...

Via Benzinga

Lantheus Downgraded Due To Reliance On PNT2002; Analyst Cites Comparable Profile To Novartis' Drug ↗

December 19, 2023

Monday, Lantheus Holdings Inc (NASDAQ: LNTH) and POINT Biopharma Global Inc (NASDAQ: PNT) reported topline data from pivotal Phase 3 SPLASH trial of 177Lu-PNT2002 in metastatic c

Via Benzinga

Performance

More News

Why is Prostate Cancer Focused Lantheus Stock Trading Lower Today? ↗

December 18, 2023

Via Benzinga

Improving Survival Rates: Biotech Innovations in Pancreatic Cancer Treatment

November 29, 2023

Via FinancialNewsMedia

Recap: POINT Biopharma Global Q3 Earnings ↗

November 13, 2023

Via Benzinga

Top 5 Health Care Stocks That May Collapse In November ↗

November 17, 2023

Via Benzinga

7 Healthcare Stocks That Are Poised to Become the Next Unicorns ↗

November 09, 2023

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023 ↗

October 24, 2023

Via Benzinga

Bristol Myers Squibb Enters the Multi-Billion-Dollar Oncology Race

October 17, 2023

Via PressReach

POINT BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of POINT Biopharma Global, Inc. - PNT

October 06, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

Stock Market Ends On High Note Even As Yields Soar; Tesla In Focus: Weekly Review ↗

October 06, 2023

Via Investor's Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023 ↗

October 06, 2023

Via Benzinga

Why Point BioPharma Global Stock Skyrocketed 86% This Week ↗

October 05, 2023

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For October 4, 2023 ↗

October 04, 2023

Via Benzinga

Why Eli Lilly Stock Was Looking Sickly Today ↗

October 03, 2023

Via The Motley Fool

Crude Oil Moves Higher; POINT Biopharma Global Shares Jump ↗

October 03, 2023

Via Benzinga

Why Shares of Point Biopharma Global Are Soaring Tuesday ↗

October 03, 2023

Via The Motley Fool

Why Getty Images Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

October 03, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 03, 2023

Via Benzinga

Nasdaq Down Over 200 Points; US Job Openings Rise In August ↗

October 03, 2023

Via Benzinga

Point Biopharma Stock Nearly Doubles On Eli Lilly Deal ↗

October 03, 2023

Via Talk Markets

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Vericity, Inc. (Nasdaq - VERY), POINT Biopharma Global, Inc. (Nasdaq - PNT), Blue Apron Holdings, Inc. (Nasdaq - APRN), Chico’s FAS, Inc. (NYSE - CHS)

October 03, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

'Airbnb Has Foundational Cracks', Disney+ Follows Netflix On Subscription Sharing Crackdown, Microsoft's Nadella Criticizes Google's Exclusive Content Deals: Today's Top Stories ↗

October 03, 2023

Via Benzinga

Vericity, POINT Biopharma Global, Oddity Tech And Other Big Stocks Moving Higher On Tuesday ↗

October 03, 2023

Via Benzinga

Dow Falls Over 100 Points; McCormick Sales Miss Views ↗

October 03, 2023

Via Benzinga

Frequently Asked Questions

Is POINT Biopharma Global Inc. - Common Stock publicly traded?

Yes, POINT Biopharma Global Inc. - Common Stock is publicly traded.

What exchange does POINT Biopharma Global Inc. - Common Stock trade on?

POINT Biopharma Global Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for POINT Biopharma Global Inc. - Common Stock?

The ticker symbol for POINT Biopharma Global Inc. - Common Stock is PNT on the Nasdaq Stock Market